Frontiers in Cancer Biotechnology Research

Explore groundbreaking studies, clinical trial updates, and emerging technologies shaping the future of cancer treatment.

Research Articles

Plasma Merger Blocked: How a $3.1 Billion Deal Clotted

Analysis of the blocked $3.1 billion merger between CSL Limited and Talecris Biotherapeutics and its impact on the plasma pharmaceutical industry

Lillian Cooper
Oct 26, 2025

Popular Articles